{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:31:43Z","timestamp":1780471903029,"version":"3.54.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1980,2,1]],"date-time":"1980-02-01T00:00:00Z","timestamp":318211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1980,2]]},"DOI":"10.1007\/bf01059447","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T14:46:02Z","timestamp":1107009962000},"page":"1-52","source":"Crossref","is-referenced-by-count":99,"title":["Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: A review"],"prefix":"10.1007","volume":"8","author":[{"given":"John G.","family":"Gambertoglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William J. C.","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Z.","family":"Benet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1980,2,1]]},"reference":[{"key":"BF01059447_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-197904020-00004","volume":"4","author":"M. E. Pickup","year":"1979","unstructured":"M. E. Pickup. Clinical pharmacokinetics of prednisone and prednisolone.Clin. Pharmacokin. 4:111\u2013128 (1979).","journal-title":"Clin. Pharmacokin."},{"key":"BF01059447_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jps.2600520626","volume":"52","author":"F. A. Campagna","year":"1963","unstructured":"F. A. Campagna, G. Cureton, R. A. Mirigian, and E. Nelson. Inactive prednisone tablets USP XVI.J. Pharm. Sci. 52:605\u2013606 (1963).","journal-title":"J. Pharm. Sci."},{"key":"BF01059447_CR3","first-page":"402","volume":"21","author":"G. Levy","year":"1964","unstructured":"G. Levy, N. A. Hall, and E. Nelson. Studies on active prednisone tablets USP XVI.Am. J. Hasp. Pharm. 21:402 (1964).","journal-title":"Am. J. Hasp. Pharm."},{"key":"BF01059447_CR4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jps.2600641035","volume":"64","author":"T. J. Sullivan","year":"1975","unstructured":"T. J. Sullivan, E. Sakmar, K. S. Albert, D. C. Blair, and J. G. Wagner.In vitro andin vivo availability of commercial prednisone tablets.J. Pharm. Sci. 64:1723\u20131725 (1975).","journal-title":"J. Pharm. Sci."},{"key":"BF01059447_CR5","first-page":"529","volume":"15","author":"E. T. Sugita","year":"1975","unstructured":"E. T. Sugita and P. J. Niebergall. Prednisone, bioavailability monograph.J. Am. Pharm. Assoc. 15:529\u2013532 (1975).","journal-title":"J. Am. Pharm. Assoc."},{"key":"BF01059447_CR6","first-page":"143","volume":"16","author":"J. J. Thiessen","year":"1976","unstructured":"J. J. Thiessen. Prednisolone, bioavailability monograph.J. Am. Pharm. Assoc. 16:143\u2013146 (1976).","journal-title":"J. Am. Pharm. Assoc."},{"key":"BF01059447_CR7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.13.9.690","volume":"13","author":"L. W. Powell","year":"1972","unstructured":"L. W. Powell and E. Axelsen. Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding.Gut 13:690\u2013696 (1972).","journal-title":"Gut"},{"key":"BF01059447_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bmj.2.5546.205","volume":"2","author":"J. S. Jenkins","year":"1967","unstructured":"J. S. Jenkins and P. A. Sampson. Conversion of cortisone to cortisol and prednisone to prednisolone.Br. Med. J. 2:205\u2013207 (1967).","journal-title":"Br. Med. J."},{"key":"BF01059447_CR9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1677\/joe.0.0140146","volume":"14","author":"C. H. Gray","year":"1956","unstructured":"C. H. Gray, M. A. S. Green, N. J. Holness, and J. B. Lunnon. Urinary metabolic products of prednisone and prednisolone.J. Endocrinol. 14:146\u2013154 (1956).","journal-title":"J. Endocrinol."},{"key":"BF01059447_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jps.2600640122","volume":"64","author":"A. R. DiSanto","year":"1975","unstructured":"A. R. DiSanto and K. A. DeSante. Bioavailability and pharmacokinetics of prednisone in humans.J. Pharm. Sci. 64:109\u2013112 (1975).","journal-title":"J. Pharm. Sci."},{"key":"BF01059447_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01086151","volume":"4","author":"T. J. Sullivan","year":"1976","unstructured":"T. J. Sullivan, M. R. Hallmark, E. Sakmar, D. J. Weidler, R. H. Earhart, and J. G. Wagner. Comparative bioavailability: Eight commercial prednisone tablets.J. Pharmacokin. Biopharm. 4:157\u2013172 (1976).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059447_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01062144","volume":"2","author":"T. J. Sullivan","year":"1974","unstructured":"T. J. Sullivan, R. G. Stoll, E. Sakmar, D. C. Blair, and J. G. Wagner.In vitro andin vivo availability of some commercial prednisolone tablets.J. Pharmacokin. Biopharm. 2:29\u201341 (1974).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059447_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01065399","volume":"5","author":"A. V. Tembo","year":"1977","unstructured":"A. V. Tembo, M. R. Hallmark, E. Sakmar, H. G. Bachman, D. J. Weidler, and J. G. Wagner. Bioavailability of prednisolone tablets,J. Pharmacokin. Biopharm. 5:257\u2013270 (1977).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059447_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-41-4-717","volume":"41","author":"A. W. Meikle","year":"1975","unstructured":"A. W. Meikle, J. A. Weed, and F. H. Tyler. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunoassays.J. Clin. Endocrinol. Metab. 41:717\u2013721 (1975).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF01059447_CR15","first-page":"138","volume":"8","author":"J. Q. Rose","year":"1978","unstructured":"J. Q. Rose, A. M. Yurchak, and W. J. Jusko. Bioavailability of two 50 mg prednisone formulations in man.Abstr. APhA Acad. Pharm. Sci. 8:138 (1978).","journal-title":"Abstr. APhA Acad. Pharm. Sci."},{"key":"BF01059447_CR16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cpt1977226912","volume":"22","author":"L. B. Petereit","year":"1977","unstructured":"L. B. Petereit and A. W. Meikle. Effectiveness of prednisolone during phenytoin therapy.Clin. Pharmacol. Ther. 22:912\u2013916 (1977).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059447_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cpt1979255part1571","volume":"25","author":"A. Tanner","year":"1979","unstructured":"A. Tanner, F. Bochner, J. Caffin, J. Halliday, and L. Powell. Dose-dependent prednisolone kinetics.Clin. Pharmacol. Ther. 25:571\u2013578 (1979).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059447_CR18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gut.19.12.1131","volume":"19","author":"M. Uribe","year":"1978","unstructured":"M. Uribe, S. W. Schalm, W. H. J. Summerskill, and V. L. W. Go. Oral prednisone for chronic active liver disease: Dose responses and bioavailability studies.Gut 19:1131\u20131135 (1978).","journal-title":"Gut"},{"key":"BF01059447_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1975.tb02778.x","volume":"2","author":"C. G. Wilson","year":"1975","unstructured":"C. G. Wilson, R. Ssendagire, C. S. May, and J. W. Paterson. Measurement of plasma prednisolone in man.Br. J. Clin. Pharmacol. 2:321\u2013325 (1975).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2125.1978.tb01664.x","volume":"5","author":"M. Davis","year":"1978","unstructured":"M. Davis, R. Williams, J. Chakraborty, J. English, V. Marks, G. Ideo, and S. Tempini. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.Br. J. Clin. Pharmacol. 5:501\u2013505 (1978).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2125.1975.tb02777.x","volume":"2","author":"B. Hulme","year":"1975","unstructured":"B. Hulme, V. H. T. James, and R. Rault. Absorption of enteric and non-enteric coated prednisolone tablets.Br. J. Clin. Pharmacol. 2:317\u2013320 (1975).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/bmj.1.6177.1534","volume":"1","author":"R. G. Henderson","year":"1979","unstructured":"R. G. Henderson, T. Wheatley, J. English, J. Chakraborty, and V. Marks. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.Br. Med. J. 1:1534\u20131536 (1979).","journal-title":"Br. Med. J."},{"key":"BF01059447_CR23","first-page":"231A","volume":"27","author":"J. Gambertoglio","year":"1979","unstructured":"J. Gambertoglio, W. Amend, F. Vincenti, N. Feduska, J. Birnbaum, and O. Salvatierra. The pharmacokinetics of prednisone in cushingoid and noncushingoid kidney transplant patients.Clin. Res. 27:231A (1979).","journal-title":"Clin. Res."},{"key":"BF01059447_CR24","unstructured":"G. Downes, J. Birnbaum, P. Lizak, F. Vincenti, N. Feduska, O. Salvatierra, and W. Amend. Separation from plasma extracts sephadex LH-20 of prednisone, cortisol and prednisolone: A rapid system. Submitted for publication."},{"key":"BF01059447_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(78)80529-0","volume":"93","author":"O. C. Green","year":"1978","unstructured":"O. C. Green, R. J. Winter, F. S. Kawahara, L. S. Phillips, P. R. Lewy, R. L. Hart, and L. M. Pachman. Pharmacokinetic studies of prednisolone in children.J. Pediatr. 93:299\u2013303 (1978).","journal-title":"J. Pediatr."},{"key":"BF01059447_CR26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM197611042951902","volume":"295","author":"D. D. Brown","year":"1976","unstructured":"D. D. Brown and R. P. Juhl. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.New Engl. J. Med. 295:1034\u20131037 (1976).","journal-title":"New Engl. J. Med."},{"key":"BF01059447_CR27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jps.3030470806","volume":"47","author":"T. Chulski","year":"1958","unstructured":"T. Chulski and A. A. Forist. The effects of some solid buffering agents in aqueous suspension on prednisolone.J. Am. Pharm. Assoc. Sci. Ed. 47:553\u2013555 (1958).","journal-title":"J. Am. Pharm. Assoc. Sci. Ed."},{"key":"BF01059447_CR28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0016-5085(73)80071-X","volume":"64","author":"A. J. Ware","year":"1973","unstructured":"A. J. Ware and B. Combes. Influence of sodium taurocholate, cholestyramine, and mylanta on the intestinal absorption of glucocorticoids in the rat.Gastroenterology 64:1150\u20131155 (1973).","journal-title":"Gastroenterology"},{"key":"BF01059447_CR29","first-page":"1021","volume":"103","author":"R. L. Galeazzi","year":"1973","unstructured":"R. L. Galeazzi, N. Gerber, and H. W. Iff. Der Einfluss von Aluminium-und Magnesiumhydroxyd (Alucol) auf die Resorption von Kortison.Schweiz. Mes. Wschr. 103:1021\u20131023 (1973).","journal-title":"Schweiz. Mes. Wschr."},{"key":"BF01059447_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2125.1979.tb00952.x","volume":"7","author":"A. R. Tanner","year":"1979","unstructured":"A. R. Tanner, J. A. Caffln, J. W. Halliday, and L. W. Powell. Concurrent administration of antacids and prednisone: Effect on serum levels of prednisolone.Br. J. Clin. Pharmacol. 7:397\u2013400 (1979).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/j.1552-4604.1976.tb01500.x","volume":"16","author":"A. V. Tembo","year":"1976","unstructured":"A. V. Tembo, E. Sakmar, M. R. Hallmark, D. J. Weidler, and J. G. Wagner. Effect of food on the bioavailability of prednisone.J. Clin. Pharmacol. 16:620\u2013624 (1976).","journal-title":"J. Clin. Pharmacol."},{"key":"BF01059447_CR32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0016-5085(76)80245-4","volume":"71","author":"M. Uribe","year":"1976","unstructured":"M. Uribe, S. W. Schalm, W. H. J. Summerskill, and V. L. W. Go. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone.Gastroen -terology 71:362\u2013364 (1976).","journal-title":"Gastroen -terology"},{"key":"BF01059447_CR33","first-page":"133","volume":"8","author":"J. W. Ayres","year":"1978","unstructured":"J. W. Ayres, M. Freundlich, S. Makker, J. Easton, M. Hallmark, T. Sudds, J. J. Mackichan, and J. G. Wagner. A clinically significant adverse drug interaction: Prednisone and aminophylline.APhA Acad. Pharm. Sci. Abstr. 8:133 (1978).","journal-title":"APhA Acad. Pharm. Sci. Abstr."},{"key":"BF01059447_CR34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0016-5085(76)80076-5","volume":"71","author":"V. Aud\u00e9tat","year":"1976","unstructured":"V. Aud\u00e9tat and J. Bircher. Bioavailability of prednisolone during simultaneous treatment with cholestyramine.Gastroenterology 71:1110\u20131111 (1976).","journal-title":"Gastroenterology"},{"key":"BF01059447_CR35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jcem-17-9-1040","volume":"17","author":"A. A. Sandberg","year":"1957","unstructured":"A. A. Sandberg and W. R. Slaunwhite. Differences in metabolism of prednisolone-C14 and cortisol-C14.J. Clin. Endocrinol. 17:1040\u20131050 (1957).","journal-title":"J. Clin. Endocrinol."},{"key":"BF01059447_CR36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1677\/joe.0.0180278","volume":"18","author":"A. Vermeulen","year":"1959","unstructured":"A. Vermeulen. The metabolism of 4-14C prednisolone.J. Endocrinol. 18:278\u2013291 (1959).","journal-title":"J. Endocrinol."},{"key":"BF01059447_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/clinchem\/17.3.161","volume":"17","author":"T. Uete","year":"1971","unstructured":"T. Uete and N. Shimano. A simple method for separate determination of delta4- and delta1,4-corticosteroids in urine.Clin. Chem. 17:161\u2013165 (1971).","journal-title":"Clin. Chem."},{"key":"BF01059447_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.1975.tb02779.x","volume":"2","author":"J. English","year":"1975","unstructured":"J. English, J. Chakraborty, V. Marks, D. J. Trigger, and A. G. Thomson. Prednisolone levels in the plasma and urine: A study of two preparations in man.Br. J. Clin. Pharmacol. 2:327\u2013332 (1975).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01061507","volume":"2","author":"R. Leclercq","year":"1974","unstructured":"R. Leclercq and G. Copinschi. Patterns of plasma levels of prednisolone after oral administration in man.J. Pharmacokin. Biopharm. 2:175\u2013187 (1974).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059447_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2125.1977.tb00792.x","volume":"4","author":"P. J. Morrison","year":"1977","unstructured":"P. J. Morrison, I. D. Bradbrook, and H. J. Rogers. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.Br. J. Clin. Pharmacol. 4:597\u2013603 (1977).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3181\/00379727-91-22307","volume":"91","author":"R. S. Ely","year":"1956","unstructured":"R. S. Ely, A. K. Done, and V. C. Kelley. \u03941-hydrocortisone: Plasma 17-hydroxycorticosteroid concentrations following oral and I.V. administration.Proc. Soc. Exp. Biol. Med. 91:503\u2013506 (1956).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF01059447_CR42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/jcem-19-5-526","volume":"19","author":"C. A. Nugent","year":"1959","unstructured":"C. A. Nugent, K. Eik-Nes, and F. H. Tyler. A comparative study of the metabolism of hydrocortisone and prednisolone.J. Clin. Endocrinol. 19:526\u2013534 (1959).","journal-title":"J. Clin. Endocrinol."},{"key":"BF01059447_CR43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/B978-1-4832-2903-4.50021-0","volume-title":"Steroid Dynamics","author":"Y. Araki","year":"1966","unstructured":"Y. Araki, O. Yokota, T. Kato, M. Kashima, and T. Miyazaki. Dynamics of synthetic corticosteroids in man. In G. Pincus, T. Nakao, and J. F. Tait (eds.),Steroid Dynamics, Academic Press, New York, 1966, pp. 463\u2013480."},{"key":"BF01059447_CR44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-38-3-407","volume":"38","author":"M. Kozower","year":"1974","unstructured":"M. Kozower, L. Veatch, and M. M. Kaplan. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects.J. Clin. Endocrinol. Metab. 38:407\u2013412 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF01059447_CR45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00609864","volume":"12","author":"M. E. Pickup","year":"1977","unstructured":"M. E. Pickup, J. R. Lowe, P. A. Leatham, V. M. Rhind, V. Wright, and W. W. Downie. Dose dependent pharmacokinetics of prednisolone.Eur. J. Clin. Phamacol. 12:213\u2013219 (1977).","journal-title":"Eur. J. Clin. Phamacol."},{"key":"BF01059447_CR46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.2042-7158.1978.tb13381.x","volume":"30","author":"J. C. K. Loo","year":"1978","unstructured":"J. C. K. Loo, I. J. McGilveray, N. Jordan, J. Moffat, and R. Brien. Dose-dependent pharmacokinetics of prednisone and prednisolone in man.J. Pharm. Pharmacol. 30:736 (1978).","journal-title":"J. Pharm. Pharmacol."},{"key":"BF01059447_CR47","doi-asserted-by":"crossref","unstructured":"J. Q. Rose, A. M. Yurchak, and W. J. Jusko. Dose-dependent pharmacokinetics of prednisolone in man. InSeventh International Congress of Pharmacology, Abstracts, Paris, 1978, p. 400.","DOI":"10.1016\/B978-0-08-023768-8.51048-3"},{"key":"BF01059447_CR48","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(71)92738-3","volume":"2","author":"G. P. Lewis","year":"1971","unstructured":"G. P. Lewis, W. J. Jusko, C. W. Burke, and L. Graves. Prednisone side-effects and serum-protein levels.Lancet 2:778\u2013781 (1971).","journal-title":"Lancet"},{"key":"BF01059447_CR49","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0016-5085(77)80209-6","volume":"72","author":"S. W. Schalm","year":"1977","unstructured":"S. W. Schalm, W. H. J. Summerskill, and V. L. W. Go. Prednisone for chronic active liver disease: Pharmacokinetics, including conversion to prednisolone.Gastroenterology 72:910\u2013913 (1977).","journal-title":"Gastroenterology"},{"key":"BF01059447_CR50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-197803040-00001","volume":"3","author":"P. duSouich","year":"1978","unstructured":"P. duSouich, A. J. McLean, D. Lalka, S. Erill, and M. Gibaldi. Pulmonary disease and drug kinetics.Clin. Pharmacokin. 3:257\u2013266 (1978).","journal-title":"Clin. Pharmacokin."},{"key":"BF01059447_CR51","first-page":"297","volume":"16","author":"J. Dwyer","year":"1967","unstructured":"J. Dwyer, L. Lazarus, and J. B. Hickie. A study of cortisol metabolism in patients with chronic asthma.Aust. Ann. Med. 16:297\u2013304 (1967).","journal-title":"Aust. Ann. Med."},{"key":"BF01059447_CR52","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(70)90283-7","volume":"2","author":"J. V. Collins","year":"1970","unstructured":"J. V. Collins, P. W. R. Harris, T. J. H. Clark, and J. Townsend. Intravenous corticosteroids in treatment of acute bronchial asthma.Lancet 2:1047\u20131049 (1970).","journal-title":"Lancet"},{"key":"BF01059447_CR53","first-page":"200","volume":"55","author":"N. P. Boye","year":"1974","unstructured":"N. P. Boye, O. Dj\u00f8seland, and H. N. Haugen. Protein-binding and metabolic clearance of cortisol in asthmatic patients.Scand. J. Resp. Dis. 55:200\u2013206 (1974).","journal-title":"Scand. J. Resp. Dis."},{"key":"BF01059447_CR54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-197904030-00005","volume":"4","author":"M. Uribe","year":"1979","unstructured":"M. Uribe and V. L. W. Go. Corticosteroid pharmacokinetics in liver disease.Clin. Pharmacokin. 4:233\u2013240 (1979).","journal-title":"Clin. Pharmacokin."},{"key":"BF01059447_CR55","first-page":"932","volume":"71","author":"M. Uribe","year":"1976","unstructured":"M. Uribe, V. L. W. Go, and W. H. J. Summerskill. Kinetics and interconversion of prednisone and prednisolone compared in chronic active liver disease (CALD) after oral doses,Gastroenterologe 71:932 (1976).","journal-title":"Gastroenterologe"},{"key":"BF01059447_CR56","first-page":"933","volume":"131","author":"A. J. Coburg","year":"1970","unstructured":"A. J. Coburg, S. H. Gray, F. H. Katz, I. Penn, C. Halgrimson, and T. E. Starzl. Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings.Surg. Gyneol. Obstet. 131:933\u2013942 (1970).","journal-title":"Surg. Gyneol. Obstet."},{"key":"BF01059447_CR57","first-page":"18","volume":"2","author":"H. S. Park","year":"1974","unstructured":"H. S. Park, J. A. Greene, and G. E. Bacon. Disappearance of high dose prednisolone from plasma after renal transplantation.Clin. Nephrol. 2:18\u201323 (1974).","journal-title":"Clin. Nephrol."},{"key":"BF01059447_CR58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archsurg.1972.04180080084014","volume":"105","author":"J. G. Turcotte","year":"1972","unstructured":"J. G. Turcotte, N. J. Feduska, E. W. Carpenter, F. D. McDonald, and G. E. Bacon. Rejection crises in human renal transplant recipients.Arch. Surg. 105:230\u2013236 (1972).","journal-title":"Arch. Surg."},{"key":"BF01059447_CR59","first-page":"651","volume":"10","author":"R. A. Sells","year":"1978","unstructured":"R. A. Sells, L. Brookes, P. Basu, and D. Whitemore. Methylprednisolone blood levels in cadaveric renal allograft recipients.Transplant. Proc. 10:651\u2013653 (1978).","journal-title":"Transplant. Proc."},{"key":"BF01059447_CR60","first-page":"1143","volume":"72","author":"M. Uribe","year":"1977","unstructured":"M. Uribe, W. H. J. Summerskill, and V. L. W. Go. Why hyperbilirubinemia and hypoalbuminemia predispose to steroid side effects during treatment of chronic active liver disease (CALD).Gastroenterology 72:1143 (1977).","journal-title":"Gastroenterology"},{"key":"BF01059447_CR61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jcem-18-1-36","volume":"18","author":"E. Englert","year":"1958","unstructured":"E. Englert, H. Brown, D. G. Willardson, S. Wallach, and E. L. Simons. Metabolism of free and conjugated 17-hydroxycorticosteroids in subjects with uremia.J. Clin. Endocrinol. 18:36\u201348 (1958).","journal-title":"J. Clin. Endocrinol."},{"key":"BF01059447_CR62","first-page":"1110","volume":"73","author":"L. Raith","year":"1967","unstructured":"L. Raith, H. J. Gurland, and H. J. Karl. Abbau und Ausscheidung von 4-14C-Cortisol nach beidseitiger Nephrektomie.Verh. Deutsch. Ges. Inn. Med. 73:1110\u20131114 (1967).","journal-title":"Verh. Deutsch. Ges. Inn. Med."},{"key":"BF01059447_CR63","first-page":"160","volume":"131","author":"M. S. Mishkin","year":"1972","unstructured":"M. S. Mishkin, T-H. Hsu, W. G. Walker, and T. Bledsoe. Studies on the episodic secretion of cortisol in uremic patients on hemodialysis.Johns Hopkins Med. J. 131:160\u2013164 (1972).","journal-title":"Johns Hopkins Med. J."},{"key":"BF01059447_CR64","first-page":"144","volume":"14","author":"P. Kramer","year":"1977","unstructured":"P. Kramer, D. Matthaei, R. Arnold, R. Ebert, D. K\u00f6bberling, C. McIntosh, E. Schwinn, F. Scheler, H. Ludwig, J. Reichel, and G. Spitella. Changes of plasma concentration and elimination of various hormones by haemofiltration.Dial. Trans. Nephrol. 14:144\u2013150 (1977).","journal-title":"Dial. Trans. Nephrol."},{"key":"BF01059447_CR65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0039-128X(77)90082-4","volume":"30","author":"P. Boer","year":"1977","unstructured":"P. Boer and J. H. H. Thijssen. The excretion of metabolites of cortisol and aldosterone in male patients on haemodialysis treatment.Steroids 30:203\u2013211 (1977).","journal-title":"Steroids"},{"key":"BF01059447_CR66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000180830","volume":"18","author":"J. E. Sherlock","year":"1977","unstructured":"J. E. Sherlock and J. M. Letteri. Effect of hemodialysis on methylprednisolone plasma levels.Nephron 18:208\u2013211 (1977).","journal-title":"Nephron"},{"key":"BF01059447_CR67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3476(76)80745-7","volume":"88","author":"S. J. Wassner","year":"1976","unstructured":"S. J. Wassner, A. J. Pennisi, M. H. Malekzadeh, and R. N. Fine. The adverse effect of anticonvulsant therapy on renal allograft survival.J. Pediatr. 88:134\u2013137 (1976).","journal-title":"J. Pediatr."},{"key":"BF01059447_CR68","first-page":"293","volume":"8","author":"S. J. Wassner","year":"1977","unstructured":"S. J. Wassner, M. H. Malekzadeh, A. J. Pennisi, R. B. Ettenger, C. H. Uittenbogaart, and R. N. Fine. Allograft survival in patients receiving anticonvulsant medications.Clin. Nephrol. 8:293\u2013297 (1977).","journal-title":"Clin. Nephrol."},{"key":"BF01059447_CR69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(76)80746-9","volume":"88","author":"P. T. McEnery","year":"1976","unstructured":"P. T. McEnery and D. A. Stempel. Commentary: Anticonvulsant therapy and renal allograft survival.J. Pediatr. 88:138\u2013139 (1976).","journal-title":"J. Pediatr."},{"key":"BF01059447_CR70","first-page":"27","volume":"176","author":"Y. Choi","year":"1971","unstructured":"Y. Choi, K. Thrasher, E. E. Werk, L. J. Sholiton, and C. Olinger. Effect of diphenylhydantoin on cortisol kinetics in humans.J. Pharmacol. Exp. Ther. 176:27\u201334 (1971).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF01059447_CR71","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI105056","volume":"43","author":"E. E. Werk","year":"1964","unstructured":"E. E. Werk, J. MacGee, and L. J. Sholiton. Effect of diphenylhydantoin on cortisol metabolism in man.J. Clin. Invest. 43:1824\u20131835 (1964).","journal-title":"J. Clin. Invest."},{"key":"BF01059447_CR72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM197007022830103","volume":"283","author":"W. Jubiz","year":"1970","unstructured":"W. Jubiz, A. W. Meikle, R. A. Levinson, S. Mizutani, C. D. West, and F. H. Tyler. Effect of diphenylhydantoin on the metabolism of dexamethasone.New Engl. J. Med. 283:11\u201314 (1970).","journal-title":"New Engl. J. Med."},{"key":"BF01059447_CR73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jcem-34-1-44","volume":"34","author":"N. Haque","year":"1972","unstructured":"N. Haque, K. Thrasher, E. E. Werk, H. C. Knowles, and L. J. Sholiton. Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin.J. Clin. Endocrinol. Metab. 34:44\u201350 (1972).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF01059447_CR74","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM197205252862103","volume":"286","author":"S. M. Brooks","year":"1972","unstructured":"S. M. Brooks, E. E. Werk, S. J. Ackerman, I. Sullivan, and K. Thrasher. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.New Engl. J. Med. 286:1125\u20131128 (1972).","journal-title":"New Engl. J. Med."},{"key":"BF01059447_CR75","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jcem-41-5-887","volume":"41","author":"M. R. Stjernholm","year":"1975","unstructured":"M. R. Stjernholm and F. H. Katz. Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate.J. Clin. Endocrinol. Metab. 41:887\u2013893 (1975).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF01059447_CR76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/ard.35.4.339","volume":"35","author":"P. M. Brooks","year":"1976","unstructured":"P. M. Brooks, W. W. Buchanan, M. Grove, and W. W. Downie. Effects of enzyme induction on metabolism of prednisolone.Ann. Rheum. Dis. 35:339\u2013343 (1976).","journal-title":"Ann. Rheum. Dis."},{"key":"BF01059447_CR77","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.1976.03270180034016","volume":"236","author":"G. A. Buffington","year":"1976","unstructured":"G. A. Buffington, J. H. Dominguez, W. F. Piering, L. A. Hebert, H. M. Kauffman, and J. Lemann. Interaction of rifampin and glucocorticoids: Adverse effect on renal allograft function.J. Am. Med. Assoc. 236:1958\u20131960 (1976).","journal-title":"J. Am. Med. Assoc."},{"key":"BF01059447_CR78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(74)91876-5","volume":"2","author":"O. M. Edwards","year":"1974","unstructured":"O. M. Edwards, R. J. Courtenay-Evans, J. M. Galley, J. Hunter, and A. D. Tait. Changes in cortisol metabolism following rifampicin therapy.Lancet 2:549\u2013551 (1974).","journal-title":"Lancet"},{"key":"BF01059447_CR79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bmj.1.6159.306","volume":"1","author":"W. Hendrickse","year":"1979","unstructured":"W. Hendrickse, J. McKiernan, M. Pickup, and J. Lowe. Rifampicin-induced nonresponsiveness to corticosteroid treatment in nephrotic syndrome.Br. Med. J. 1:306 (1979).","journal-title":"Br. Med. J."},{"key":"BF01059447_CR80","first-page":"1020","volume":"1","author":"W. Marle Van","year":"1979","unstructured":"W. Van Marle, K. L. Woods, and L. Beeley. Concurrent steroid and rifampicin therapy.Lancet 1:1020 (1979).","journal-title":"Lancet"},{"key":"BF01059447_CR81","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1965.03090190023006","volume":"194","author":"J. R. Klinenberg","year":"1965","unstructured":"J. R. Klinenberg and F. Miller. Effect of corticosteroids on blood salicylate concentration.J. Am. Med. Assoc. 194:131\u2013134 (1965).","journal-title":"J. Am. Med. Assoc."},{"key":"BF01059447_CR82","first-page":"500","volume":"5","author":"G. Graham","year":"1975","unstructured":"G. Graham, G. D. Champion, R. O. Day, and P. D. Paull. Pharmacokinetics of salicylate in subjects with rheumatoid arthritis.Aust. N.Z. J. Med. 5:500 (1975).","journal-title":"Aust. N.Z. J. Med."},{"key":"BF01059447_CR83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cpt1977224410","volume":"22","author":"G. G. Graham","year":"1977","unstructured":"G. G. Graham, G. D. Champion, R. O. Day, and P. D. Paull. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.Clin. Pharmacol. Ther. 22:410\u2013420 (1977).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059447_CR84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/adc.53.5.381","volume":"53","author":"M. Bardare","year":"1978","unstructured":"M. Bardare, G. U. Cislaghi, M. Mandelli, and F. Sereni. Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis.Arch. Dis. Child. 53:381\u2013385 (1978).","journal-title":"Arch. Dis. Child."},{"key":"BF01059447_CR85","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1139\/y77-051","volume":"55","author":"P. Kourounakis","year":"1977","unstructured":"P. Kourounakis and H. Selye. Actions of prednisolone acetate, pregnenolone-16\u03b1carbonitrite, and triamcinolone upon drug resistance and metabolism: A comparative study.Can. J. Physiol. Pharmacol. 55:363\u2013366 (1977).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"BF01059447_CR86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-2952(69)90017-3","volume":"18","author":"T. Hayakawa","year":"1969","unstructured":"T. Hayakawa, N. Kanai, R. Yamada, R. Kuroda, H. Higashi, H. Mogami, and D. Jinnai. Effect of steroid hormone on activation of endoxan (cyclophosphamide).Biochem. Pharmacol. 18:129\u2013135 (1969).","journal-title":"Biochem. Pharmacol."},{"key":"BF01059447_CR87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0006-2952(72)90280-8","volume":"21","author":"G. K. Hanasono","year":"1972","unstructured":"G. K. Hanasono and L. J. Fischer. Plasma levels and urinary excretion of [14C]cyclophosphamide and its radioactive metabolites in rats pretreated with prednisolone.Biochem. Pharmacol. 21:272\u2013276 (1972).","journal-title":"Biochem. Pharmacol."},{"key":"BF01059447_CR88","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/03602537608995839","volume":"5","author":"W. J. Jusko","year":"1976","unstructured":"W. J. Jusko and M. Gretch. Plasma and tissue protein binding of drugs in pharmacokinetics.Drug. Metab. Rev. 5:43\u2013140 (1976).","journal-title":"Drug. Metab. Rev."},{"key":"BF01059447_CR89","unstructured":"W. J. Jusko. Pharmacokinetics in disease states changing protein binding. In L. Z. Benet (ed.),The Effect of Disease States on Drug Pharmacokinetics, American Pharmaceutical Association, Academy of Pharmaceutical Sciences, 1976, pp. 99\u2013123."},{"key":"BF01059447_CR90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/jcem-17-3-395","volume":"17","author":"W. R. Slaunwhite","year":"1957","unstructured":"W. R. Slaunwhite and A. A. Sandberg. The metabolism of 1-dehydro-17-hydroxycorticosteroids in human subjects.J. Clin. Endocrinol. Metab. 17:395\u2013406 (1957).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF01059447_CR91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/joe.0.0230129","volume":"23","author":"P. S. Chen","year":"1961","unstructured":"P. S. Chen, I. H. Mills, and F. C. Bartter. Ultrafiltration studies of steroid-protein binding.J. Endocrinol. 23:129\u2013137 (1961).","journal-title":"J. Endocrinol."},{"key":"BF01059447_CR92","first-page":"35","volume":"32","author":"F. Centeno","year":"1978","unstructured":"F. Centeno, G. Robles, M. Uribe, S. G. Lozada, and G. I. Su\u00e1rez. Nomogram for prednisone-prednisolone adjustment dose in patients with hypoalbuminemia.Rev. Invest. Clin. (Mex.) 32:35\u201339 (1978).","journal-title":"Rev. Invest. Clin. (Mex.)"},{"key":"BF01059447_CR93","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0016-5085(76)80245-4","volume":"71","author":"M. Uribe","year":"1976","unstructured":"M. Uribe, A. M. Wolf, and W. H. J. Summerskill. Steroid side effects during therapy of chronic active liver disease (CALD): What to expect.Gastroenterology 71:932 (1976).","journal-title":"Gastroenterology"},{"key":"BF01059447_CR94","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cpt197823147","volume":"23","author":"A. Angeli","year":"1978","unstructured":"A. Angeli, R. Frajria, R. De Paoli, D. Fonzo, and F. Ceresa. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.Clin. Pharmacol. Ther. 23:47\u201353 (1978).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059447_CR95","first-page":"1030","volume":"73","author":"G. E. Bacon","year":"1969","unstructured":"G. E. Bacon and S. Kokenakes. Measurement of plasma prednisolone by gas chromatography.J. Lab. Clin. Med. 73:1030\u20131035 (1969).","journal-title":"J. Lab. Clin. Med."},{"key":"BF01059447_CR96","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jps.2600600705","volume":"60","author":"P. F. D'Arcy","year":"1971","unstructured":"P. F. D'Arcy, J. P. Griffin, J. S. Jenkins, W. F. Kirk, and A. W. C. Peacock. Sustainedrelease formulation of prednisolone administered orally to man.J. Pharm. Sci. 60:1028\u20131033 (1971).","journal-title":"J. Pharm. Sci."},{"key":"BF01059447_CR97","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jcem-27-7-973","volume":"27","author":"B. E. P. Murphy","year":"1967","unstructured":"B. E. P. Murphy. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.J. Clin. Endocrinol. 27:973\u2013990 (1967).","journal-title":"J. Clin. Endocrinol."},{"key":"BF01059447_CR98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/000456327401100103","volume":"11","author":"J. English","year":"1974","unstructured":"J. English, J. Chakraborty, and V. Marks. A competitive protein binding method for plasma prednisolone assay.Ann. Clin. Biochem. 11:11\u201314 (1974).","journal-title":"Ann. Clin. Biochem."},{"key":"BF01059447_CR99","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-2944(70)90066-9","volume":"4","author":"D. H. Sandberg","year":"1970","unstructured":"D. H. Sandberg, C. Z. Bacallao, and W. W. Cleveland. Measurement of plasma prednisolone by a competitive protein-binding assay.Biochem. Med. 4:383\u2013390 (1970).","journal-title":"Biochem. Med."},{"key":"BF01059447_CR100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/clinchem\/19.7.731","volume":"19","author":"A. K. Turner","year":"1973","unstructured":"A. K. Turner, C. J. Carroll, J. L. Pinkus, D. Charles, and S. C. Chattaoraj. Simultaneous competitive protein binding assay for cortisol, cortisone, and prednisolone in plasma and its clinical application.Clin. Chem. 19:731\u2013736 (1973).","journal-title":"Clin. Chem."},{"key":"BF01059447_CR101","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0039-128X(73)90124-4","volume":"21","author":"W. A. Colburn","year":"1973","unstructured":"W. A. Colburn and R. H. Buller. Radioimmunoassay for prednisolone.Steroids 21:833\u2013846 (1973).","journal-title":"Steroids"},{"key":"BF01059447_CR102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0039-128X(74)90048-8","volume":"24","author":"W. A. Colburn","year":"1974","unstructured":"W. A. Colburn. Radioimmunoassay for prednisone.Steroids 24:95\u2013106 (1974).","journal-title":"Steroids"},{"key":"BF01059447_CR103","first-page":"761","volume":"51","author":"S. W. Schalm","year":"1976","unstructured":"S. W. Schalm, W. H. J. Summerskill, and V. L. W. Go. Development of radioimmunoassays for prednisone and prednisolone: Application to studies of hepatic metabolism of prednisone.Mayo Clin. Proc. 51:761\u2013766 (1976).","journal-title":"Mayo Clin. Proc."},{"key":"BF01059447_CR104","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0160-5402(78)90052-9","volume":"1","author":"J. A. Caffin","year":"1978","unstructured":"J. A. Caffin, J. W. Halliday, and L. W. Powell. Specific assays for prednisolone and prednisone in serum: Lipidex chromatography followed by radioimmunoassay.J. Phar. Meth. 1:223\u2013231 (1978).","journal-title":"J. Phar. Meth."},{"key":"BF01059447_CR105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2125.1976.tb00645.x","volume":"3","author":"J. Chakraborty","year":"1976","unstructured":"J. Chakraborty, J. English, V. Marks, M. C. Dumasia, and D. J. Chapman. A radioimmunoassay method for prednisolone: Comparison with the competitive protein binding method.Br. J. Clin. Pharmacol. 3:903\u2013906 (1976).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF01059447_CR106","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0039-128X(76)90048-9","volume":"28","author":"A. V. Tembo","year":"1976","unstructured":"A. V. Tembo, M. A. Schork, and J. G. Wagner. Statistical survey of \u201csaturation analysis\u201d calibration curve data for prednisolone, prednisone and digoxin.Steroids 28:387\u2013403 (1976).","journal-title":"Steroids"},{"key":"BF01059447_CR107","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jps.2600670713","volume":"67","author":"S. B. Matin","year":"1978","unstructured":"S. B. Matin and B. Amos. Quantitative determination of prednisone and prednisolone in human plasma using GLC and chemical-ionization mass spectrometry.J. Pharm. Sci. 67:923\u2013926 (1978).","journal-title":"J. Pharm. Sci."},{"key":"BF01059447_CR108","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0378-4347(00)81807-1","volume":"143","author":"J. C. K. Loo","year":"1977","unstructured":"J. C. K. Loo, A. G. Butterfield, J. Moffat, and N. Jordon. Analysis of prednisolone in plasma by high-performance liquid chromatography.J. Chromatogr. 143:275\u2013280 (1977).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR109","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0378-4347(00)81812-5","volume":"143","author":"J. C. K. Loo","year":"1977","unstructured":"J. C. K. Loo and N. Jordan. High-performance liquid chromatographie analysis for synthetic corticosteroids in plasma.J. Chromatogr. 143:314\u2013316 (1977).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-4347(00)81514-5","volume":"162","author":"J. Q. Rose","year":"1979","unstructured":"J. Q. Rose and W. J. Jusko. Corticosteroid analysis in biological fluids by highperformance liquid chromatography.J. Chromatogr. 162:273\u2013280 (1979).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9673(00)82761-2","volume":"107","author":"K. F. Trefz","year":"1975","unstructured":"K. F. Trefz, D. J. Byrd, and W. Kochen. Quantitative determination of cortisol in human plasma by high-pressure liquid chromatography.J. Chromatogr. 107:181\u2013189 (1975).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR112","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0378-4347(00)81317-1","volume":"143","author":"C. P. DeVries","year":"1977","unstructured":"C. P. DeVries, C. Popp-Snijders, W. De Kieviet, and A. C. Akkerman-Faber. Use of high-pressure liquid chromatography in the assay of aldosterone in urine.J. Chromatogr. 143:624\u2013627 (1977).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR113","first-page":"137","volume":"18","author":"D. C. Garg","year":"1977","unstructured":"D. C. Garg, J. W. Ayres, and J. G. Wagner. Determination of methylprednisolone and hydrocortisone in plasma using high pressure liquid chromatography.Res. Commun. Chem. Pathol. Pharmacol. 18:137\u2013146 (1977).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"BF01059447_CR114","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/clinchem\/25.7.1293","volume":"25","author":"P. M. Kabra","year":"1979","unstructured":"P. M. Kabra, L. L. Tsai, and L. J. Marton. Improved liquid Chromatographie method for determination of serum cortisol.Clin. Chem. 25:1293\u20131296 (1979).","journal-title":"Clin. Chem."},{"key":"BF01059447_CR115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/clinchem\/25.1.122","volume":"25","author":"G. E. Reardon","year":"1979","unstructured":"G. E. Reardon, A. M. Caldarella, and E. Canalis. Determination of serum cortisol and 11-deoxycortisol by liquid chromatography.Clin. Chem. 25:122\u2013126 (1979).","journal-title":"Clin. Chem."},{"key":"BF01059447_CR116","first-page":"124","volume":"53","author":"V. K. H. M\u00fcller","year":"1978","unstructured":"V. K. H. M\u00fcller and B. Stuber. Hochdruckfl\u00fcssigkeitschromatographie von Prednisolon und Hexachlorophen.Pharm. Acta Helv. 53:124 (1978).","journal-title":"Pharm. Acta Helv."},{"key":"BF01059447_CR117","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-4347(00)81341-9","volume":"145","author":"S. E. Tsuei","year":"1978","unstructured":"S. E. Tsuei, J. J. Ashley, B. G. Moore, and W. G. McBride. Quantitation of dexamethasone in biological fluids using high-performance liquid chromatography.J. Chromatogr. 145:213\u2013220 (1978).","journal-title":"J. Chromatogr."},{"key":"BF01059447_CR118","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/clinchem\/25.11.1944","volume":"25","author":"F. J. Frey","year":"1979","unstructured":"F. J. Frey, B. M. Frey, and L. Z. Benet. Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.Clin. Chem. 25:1944\u20131947 (1979).","journal-title":"Clin. Chem."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01059447\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:40:59Z","timestamp":1586094059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01059447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,2]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1980,2]]}},"alternative-id":["BF01059447"],"URL":"https:\/\/doi.org\/10.1007\/bf01059447","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1980,2]]}}}